Cornelius Remschmidt

2.9k citations

41 papers · 1.5k indexed · h-index 25

Impact in

Health top 2%
- Vaccine Coverage and Hesitancy
Modeling and Simulation top 2%
- COVID-19 epidemiological studies

Papers in

Applied Microbiology and Biotechnology 4
- Antibiotic Use and Resistance 4
Modeling and Simulation 4
- COVID-19 epidemiological studies 4

Co-authors: Ole Wichmann Thomas Harder Petra Gastmeier Gerhard Falkenhorst Christian Bogdan Birte Bödeker Michael Behnke Udo Buchholz
Journals: BMC Infectious Diseases (6 papers)Human Vaccines & Immunotherapeutics (3 papers)Vaccine (3 papers)BMC Public Health (3 papers)Antimicrobial Resistance and Infection Control (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Cornelius Remschmidt

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by Cornelius Remschmidt

Since Specialization

Citations

This map shows the geographic impact of Cornelius Remschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelius Remschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelius Remschmidt more than expected).

Fields of papers citing papers by Cornelius Remschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelius Remschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelius Remschmidt. The network helps show where Cornelius Remschmidt may publish in the future.

Co-authors

The 25 scholars most cited alongside Cornelius Remschmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cornelius Remschmidt Line = papers co-authored together Cornelius Remschmidt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility Study on Menstrual Cycles With Fitbit Device (FEMFIT): Prospective Observational Cohort Study JMIR mhealth and uhealth ·Park Yong Sin, 信洋横井, Junainah Mohamad, C. Ai, Halyna Sakalova, G. A. Rohrer, 眞佐子杉谷, Cornelius Remschmidt	2024	1
2	COVID-19 Vaccine Effectiveness and Digital Pandemic Surveillance in Germany (eCOV Study): Web Application–Based Prospective Observational Cohort Study Journal of Medical Internet Research ·Park Yong Sin, 禹艳群, S Amplatz, Stefan Konigorski, Stefan Scholz, Felix Balzer, Cornelius Remschmidt, Rasmus Leistner	2024	2
3	Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance Antimicrobial Resistance and Infection Control ·Cornelius Remschmidt, C. Schröder, Michael Behnke, Petra Gastmeier, Christine Geffers, Tobias Siegfried Kramer	2018	97
4	Factors associated with parental acceptance of seasonal influenza vaccination for their children – A telephone survey in the adult population in Germany Vaccine ·K S Anju, Zavala Gombeira, Patrick Schmich, Matthias Wetzstein, Ole Wichmann, Cornelius Remschmidt	2017	22
5	The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study Antimicrobial Resistance and Infection Control ·Cornelius Remschmidt, Michael Behnke, Axel Kola, Luis Alberto Peña Diaz, Anna M. Rohde, Petra Gastmeier, Frank Schwab	2017	33
6	Is the impact of childhood influenza vaccination less than expected: a transmission modelling study BMC Infectious Diseases ·Tuba Dilfiruz, Cornelius Remschmidt, Silke Buda, Udo Buchholz, B. Ultsch, Ole Wichmann	2017	24
7	Use of existing systematic reviews for evidence assessments in infectious disease prevention: a comparative case study Systematic Reviews ·Thomas Harder, Cornelius Remschmidt, Sebastian Haller, Tim Eckmanns, Ole Wichmann	2016	7
8	A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness Value in Health ·Oliver Damm, S. Scholz, B. Ultsch, Tuba Dilfiruz, Cornelius Remschmidt, Ole Wichmann, Wolfgang Greiner	2016	4
9	Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Gerhard Falkenhorst, Cornelius Remschmidt, Thomas Harder, Ole Wichmann, Shahzad Memon, Eva Hummers, Thomas Ledig, Christian Bogdan	2016	30
10	Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren) Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Cornelius Remschmidt, Thomas Harder, Ole Wichmann, Edeltraut Garbe, Thomas Ledig, Sean P. Adamson, Sabine Wicker, Fred Zepp, Thomas Mertens	2016	5
11	Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany BMC Infectious Diseases ·Cornelius Remschmidt, Thorsten Rieck, Birte Bödeker, Ole Wichmann	2015	14
12	Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study BMC Public Health ·Birte Bödeker, Cornelius Remschmidt, Patrick Schmich, Ole Wichmann	2015	83
13	Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site Human Vaccines & Immunotherapeutics ·Cornelius Remschmidt, Dietmar Walter, Patrick Schmich, Matthias Wetzstein, Yvonne Deleré, Ole Wichmann	2014	35
14	Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies BMC Public Health ·Cornelius Remschmidt, Destri Tri Utami, Andreas M. Kaufmann, Yvonne Deleré	2014	26
15	Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling BMC Infectious Diseases ·Yvonne Deleré, Cornelius Remschmidt, V. V. Milyavsky, Melanie Schuster, Destri Tri Utami, Achim Schneider, Ole Wichmann, Andreas M. Kaufmann	2014	46
16	Background paper to the recommendation for routine rotavirus vaccination of infants in Germany Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Judith Koch, Miriam Wiese‐Posselt, Cornelius Remschmidt, Ole Wichmann, Ryohei Shimanuki, Edeltraut Garbe, Hartmut Hengel, Joerg J Meerpohl, Andreas Mas Marques, H Oppermann, Eva Hummers, Rüdiger von Kries, Thomas Mertens	2013	26
17	Background paper to the revised recommendation for hepatitis B vaccination of persons at particular risk and for hepatitis B postexposure prophylaxis in Germany Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Thomas Harder, Cornelius Remschmidt, Gerhard Falkenhorst, Ruth Zimmermann, Hartmut Hengel, Thomas Ledig, H Oppermann, Stefan Zeuzem, Sabine Wicker	2013	18
18	Preventable and non-preventable risk factors for influenza transmission and hygiene behavior in German influenza households, pandemic season (H1N1) 2009/2010 Influenza and Other Respiratory Viruses ·Cornelius Remschmidt, M K Köhler, Matthias an der Heiden, Thorsten Suess, Wei Zhou, Susanne Schink, Brunhilde Schweiger, Walter Haas, Udo Buchholz	2012	8
19	The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011 BMC Infectious Diseases ·Thorsten Suess, Cornelius Remschmidt, Susanne Schink, Brunhilde Schweiger, Andreas Nitsche, 戚红梅, Joerg Doellinger, S. Tàsies, Walter Haas, Mark A. Butchko, Gérard Krause, Udo Buchholz	2012	140
20	Sweet and sour--a patient with life-threatening metabolic acidosis and acute renal failure Clinical Kidney Journal ·Zsolt Bertalan, D Fischer, Cornelius Remschmidt, Gunnar Schley, A. C. Walker, Fabienne Aregger	2008	2

About Cornelius Remschmidt

Cornelius Remschmidt is a scholar working on Applied Microbiology and Biotechnology, Modeling and Simulation, Epidemiology, Health and Clinical Biochemistry, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Respiratory viral infections research (17 papers), Influenza Virus Research Studies (17 papers), Pneumonia and Respiratory Infections (7 papers), Vaccine Coverage and Hesitancy (7 papers), Cervical Cancer and HPV Research (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), COVID-19 epidemiological studies (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Health (311 citations), Modeling and Simulation (165 citations), Applied Microbiology and Biotechnology (54 citations), Epidemiology (875 citations) and Infectious Diseases (451 citations). Cornelius Remschmidt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ole Wichmann, Thomas Harder, Petra Gastmeier, Gerhard Falkenhorst, Christian Bogdan, Birte Bödeker, Michael Behnke, Udo Buchholz, Eva Hummers and Patrick Schmich. Their work appears in journals such as BMC Infectious Diseases, Human Vaccines & Immunotherapeutics, Vaccine, BMC Public Health and Antimicrobial Resistance and Infection Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact